More Globe Newswire

View Older Stories View Newer Stories

Oct 30, 2025 08:00AM Arcutis Launches ZORYVE® (roflumilast) Cream 0.05% for the Treatment of Mild to Moderate Atopic Dermatitis in Children Ages 2 to 5
Oct 30, 2025 08:00AM Ultragenyx Announces First Patient Dosed in Aurora Study Evaluating GTX-102 in Additional Angelman Syndrome Genotypes and Age Groups
Oct 30, 2025 08:00AM Rick Sherlund, Wall Street Legend, joins in Partnership with Wedbush Tech Investment Banking
Oct 30, 2025 08:00AM Celularity and DefEYE, Inc. Partner to Advance Growth of Regenerative Therapies in Eye Care
Oct 30, 2025 08:00AM Biomea Fusion to Present Poster Presentations at ObesityWeek®2025
Oct 30, 2025 08:00AM SunPower Executes Major Sales Force Expansion Following Sunder Merger
Oct 30, 2025 08:00AM Workhorse Reminds Shareholders to Vote Today FOR All Proposals
Oct 30, 2025 08:00AM Monster Beverage to Report Financial Results for 2025 Third Quarter on November 6, 2025
Oct 30, 2025 08:00AM Incannex Provides Shareholder Update Highlighting Clinical Progress, Capital Discipline, and EOY 2025 Strategic Focus
Oct 30, 2025 08:00AM ZenaTech to Highlight Drone as a Service, AI Drone Solutions, and US Defense Initiatives at Three Upcoming Investor Conferences
Oct 30, 2025 08:00AM Rumble Announces Timing of Third Quarter 2025 Earnings Release and Conference Call
Oct 30, 2025 08:00AM Calidi Biotherapeutics Announces New Data to be Presented on its Therapeutic Lead, CLD-401, at the 2025 SITC Annual Meeting
Oct 30, 2025 08:00AM Kinetic Teams Up With eero to Deliver Next-Gen Secure Home Wi-Fi
Oct 30, 2025 08:00AM Harvard Bioscience Schedules Third Quarter 2025 Earnings Conference Call for November 6, 2025 at 8:00 AM ET
Oct 30, 2025 08:00AM Solid Biosciences to Participate at Upcoming Investor Conferences
Oct 30, 2025 08:00AM Lisata Therapeutics to Report Third Quarter 2025 Financial Results and Provide a Business Update on Thursday, November 6, 2025
Oct 30, 2025 08:00AM 23andMe Research Institute Appoints Privacy Advisory Board
Oct 30, 2025 08:00AM Barry Hytinen Appointed to ABM’s Board of Directors
Oct 30, 2025 08:00AM Edible Garden Receives Preliminary Approval to Sell Up to $3.35 Million in Tax Credits Through NJEDA Program
Oct 30, 2025 08:00AM UroGen Pharma to Report Third Quarter 2025 Financial Results on Thursday, November 6th, 2025
Oct 30, 2025 08:00AM Pacira to Report Third Quarter 2025 Financial Results on Thursday November 6, 2025
Oct 30, 2025 08:00AM T-knife Therapeutics Announces Four Upcoming Data Presentations on PRAME-Targeted TK-6302 at the Society for Immunotherapy of Cancer (SITC) Annual Meeting
Oct 30, 2025 08:00AM Kojamo plc’s Interim Report 1 January–30 September 2025
Oct 30, 2025 08:00AM Rani Therapeutics to Present Preclinical Data on Oral Delivery of Semaglutide via the RaniPill® Capsule at ObesityWeek® 2025
Oct 30, 2025 08:00AM Harvia will publish its Interim report for January–September 2025 on Thursday, 6 November 2025 at around 9:00 a.m. EET
Oct 30, 2025 08:00AM Municipality Finance will redeem early notes issued under its MTN programme
Oct 30, 2025 08:00AM Evaxion raises $7.2 million, extending cash runway to second half of 2027
Oct 30, 2025 08:00AM OrganOx Completes Acquisition by Terumo Corporation to Advance the Future of Organ Transplantation
Oct 30, 2025 07:55AM Ramsey Theory Group CEO Dan Herbatschek Urges Enterprises to Prepare for Post-SaaS Era as AI Agents Reshape Software Delivery and Licensing Models
Oct 30, 2025 07:55AM Clearmind Medicine Completes First Cohort Treatment in its FDA-Approved Phase I/IIa Clinical Trial for Alcohol Use Disorder
Oct 30, 2025 07:40AM CMS (867.HK; 8A8.SG) NDA for AD Indication of Long-acting Anti-IL-4Rα Humanized Monoclonal Antibody Injection MG-K10 Accepted in China
Oct 30, 2025 07:30AM First National Corporation Reports Record Third Quarter 2025 Earnings
Oct 30, 2025 07:30AM Lancaster Resources LiDAR Results and Field Trip Data from Lake Cargelligo Gold Project
Oct 30, 2025 07:30AM Dynacor Begins Plant Shipments to Senegal; Continues Ecuador Integration
Oct 30, 2025 07:30AM Knight Therapeutics Announces Approval and Launch of MINJUVI® (tafasitamab) in Argentina
Oct 30, 2025 07:30AM DT Midstream Reports Strong Third Quarter 2025 Results; Raises Adjusted EBITDA Guidance
Oct 30, 2025 07:30AM Altimmune to Report Third Quarter 2025 Financial Results and Provide Business Update on November 6, 2025
Oct 30, 2025 07:30AM Notice of Knight Therapeutics' Third Quarter 2025 Results Conference Call
Oct 30, 2025 07:30AM FG Nexus Announces Listing on Deutsche Börse in Germany U.S. NASDAQ Ticker is FGNX and German Borse Ticker is LU51
Oct 30, 2025 07:30AM Turn Therapeutics Enters Global Supply, Development, and License Agreement with Leading Medical-Surgical Product Manufacturer and Distributor Medline
Oct 30, 2025 07:30AM Foghorn Therapeutics Announces Updates for Selective ARID1B, Selective CBP and Selective EP300 Degrader Programs
Oct 30, 2025 07:30AM Digi Power X to Announce 2025 Q3 Financial Results on November 13th
Oct 30, 2025 07:30AM Laureate Education Reports Financial Results for the Third Quarter and Nine Months Ended September 30, 2025
Oct 30, 2025 07:30AM Brixton Metals Makes Copper-Gold Porphyry Discovery at the Catalyst Target on its Thorn Project
Oct 30, 2025 07:30AM Profusa Outlines Potential Path to $250 Million Revenue by 2030, Driven by Sequential Lumee™ Oxygen and Glucose Monitoring Launches
Oct 30, 2025 07:30AM SIGA to Host Business Update Call on November 6, 2025 Following Release of Third-Quarter 2025 Results
Oct 30, 2025 07:30AM Saia Reports Third Quarter Results
Oct 30, 2025 07:30AM Applied Materials to Report Fourth Quarter and Fiscal 2025 Results on Nov. 13, 2025
Oct 30, 2025 07:30AM Epicured Appoints Industry Veteran Patricia Bradley to Oversee Life Sciences Business
Oct 30, 2025 07:29AM FreshBooks and Stride Expand Health Benefits Access for U.S. Small Businesses
View Newer Stories View Older Stories